Home › Funds › Amitell Capital Pte Ltd › RCKT
Amitell Capital Pte Ltd position in RCKT
ROCKET PHARMACEUTICALS INC · Health Care
Amitell Capital Pte Ltd reported holding 178,769 shares of RCKT (ROCKET PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$470K, representing 0.45% of its reported portfolio and ranking #23 among its reported holdings. Amitell Capital Pte Ltd has disclosed RCKT holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Amitell Capital Pte Ltd's RCKT position evolved
Amitell Capital Pte Ltd first disclosed a stake in RCKT in Q2 2025 at 227,000 shares (US$556K). The position peaked in Q1 2026 at 178,769 shares, worth US$640K. Across 6 filings, Amitell Capital Pte Ltd increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 178,769 shares valued at US$470K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 227.00K | $556.15K | New |
| Q3 2025 | 178.77K | $582.79K | Reduce |
| Q4 2025 | 178.77K | $627.48K | Hold |
| Q1 2026 | 178.77K | $639.99K | Hold |
| Q2 2026 | 178.77K | $611.39K | Hold |
| Q3 2026 | 178.77K | $470.16K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RCKT and 13F data
RCKT (ROCKET PHARMACEUTICALS INC) is a Health Care company. 15 other funds we track also report a position in RCKT — the largest reported positions include RTW INVESTMENTS, LP (US$60.5M), Newtyn Management, LLC (US$13.7M), Maverick Capital (US$13.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RCKT
- RTW INVESTMENTS, LP 17.69M sh · $60.49M · Q2 2026
- Newtyn Management, LLC 4.00M sh · $13.68M · Q2 2026
- Maverick Capital 3.92M sh · $13.42M · Q2 2026
- MAVERICK CAPITAL LTD 3.92M sh · $13.42M · Q2 2026
- Monaco Asset Management SAM 2.92M sh · $7.68M · Q3 2026
More on Amitell Capital Pte Ltd
FAQ
How long has Amitell Capital Pte Ltd held RCKT?
Amitell Capital Pte Ltd has disclosed RCKT holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is Amitell Capital Pte Ltd's current position in RCKT?
As of Q3 2026, Amitell Capital Pte Ltd holds 178.77K shares of RCKT (ROCKET PHARMACEUTICALS INC), valued at $470.16K, representing 0.45% of its reported portfolio and ranking #23.
Has Amitell Capital Pte Ltd been buying or selling RCKT?
In the latest 13F filing (Q3 2026), Amitell Capital Pte Ltd held unchanged its position in RCKT. The position peaked in Q1 2026 at 178.77K shares.
Which other funds hold RCKT?
Other major institutional holders of RCKT include RTW INVESTMENTS, LP, Newtyn Management, LLC, Maverick Capital, among 15 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.